The global IVD quality control market size is expected
to reach USD 1.24 billion by 2026, according to a new report by Grand View
Research, Inc. The market is projected to witness a CAGR of 4.1% over the
forecast period. Continually evolving technology-oriented changes in the
diagnostics field and growing need to ensure patient safety necessitate the
implementation of quality assurance programs in various medical disciplines
including radiology and Point-of-Care (PoC) devices. Patients rely on
self-testing IVD devices for long-term disease management and hence it is
important for such devices to be checked, in terms of result reproducibility
and validity, to guarantee patient safety.
Rising number of certified clinical
laboratories offering dependable IVD-based diagnostic services directly
correlates with increased patient confidence, thus driving the market. In
addition to quality assessments, amendments to the regulatory framework are
made intermittently to enhance the existing standards with the main objective
of safeguarding qualitative superiority of the diagnostic services. In May
2016, the European Union passed an agreement to update the pre-existing
regulations pertaining to IVD devices, wherein the updates were in concern with
raising the patient safety levels, particularly for disabled persons. The
presence of third-party agencies for independent assessment of the IVD devices
is expected to elevate the current safety standards, which will drive the In
Vitro Diagnostics (IVD) Quality Control market further.
Browse full research report on In
Vitro Diagnostics Quality Control Market:
https://www.grandviewresearch.com/industry-analysis/in-vitro-diagnostics-ivd-quality-control-market
Further key
findings from the study suggest:
- In 2018, the clinical chemistry was the
second-largest application segment of the global IVD market, in terms of
market share
- Demand for preventive medicine and rapid
transformation of clinical laboratories into highly automated and
efficient businesses are some of the factors for the segment’s growth
- Molecular diagnostics is projected to be the
fastest-growing segment due to increasing technical complexity of
molecular diagnostic testing and need for quality evaluation to ensure
standards
- These tests are of prime importance as the
outcomes enable healthcare practitioners make critical treatment decisions
- Hospitals was the largest segment in 2018 due
to the presence of advanced technology-based devices like Next Generation
Sequencing (NGS) and microarrays, and rising applications of the optimized
quality-control procedures
- North America was the dominant regional market
in 2018 due to the presence of over 150,000 registered diagnostics labs
and is likely to maintain the dominance throughout the forecast years
- Siemens Healthcare GmbH; Roche Diagnostics;
Alere, Inc.; Abbott Laboratories, Inc.; Qiagen N.V.; Bio-Rad Laboratories,
Inc.; Quidel Corp.; Becton, Dickinson and Company; bioMerieux, Inc.;
Sysmex Corp.; Sero AS; and Thermo Fisher Scientific, Inc. are some of the
key companies in the global market
Browse request sample of this report by
Grand View Research:
https://www.grandviewresearch.com/industry-analysis/in-vitro-diagnostics-ivd-quality-control-market/request/rs1
Grand
View Research has segmented the global IVD quality control market on the basis
of application, type, end use, and region:
- Immunochemistry
- Hematology
- Clinical Chemistry
- Molecular Diagnostics
- Coagulation
- Microbiology
- Others
IVD Quality
Control Type Outlook (Revenue, USD Million, 2014 - 2026)
- Quality Control
- Quality Controls,
by Type
- Plasma-based
Control
- Serum-based
Control
- Whole Blood-based
Control
- Others
- Quality Controls,
by Application
- Immunochemistry
- Hematology
- Clinical Chemistry
- Molecular
Diagnostics
- Coagulation
- Microbiology
- Others
- Quality Assurance
Services
- Immunochemistry
- Hematology
- Clinical Chemistry
- Molecular
Diagnostics
- Coagulation
- Microbiology
- Others
- Data Management
- Clinical Chemistry
- Immunochemistry
- Hematology
- Molecular
Diagnostics
- Coagulation
- Microbiology
- Others
IVD Quality
Control End Use Outlook (Revenue, USD Million, 2014 - 2026)
- Hospitals
- Laboratories
- Home-care
- Others
IVD Quality
Control Regional Outlook (Revenue, USD Million, 2014 - 2026)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Asia Pacific
- Japan
- China
- India
- South Korea
- Singapore
- Australia
- Latin America
- Brazil
- Argentina
- Middle East &
Africa
- South Africa
- UAE
- Saudi Arabia
About Grand View Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
No comments:
Post a Comment